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Original Communication
Clinical Relevancy Statement
Dietary management of ulcerative colitis may be an effective 
therapy for maintaining patients with this inflammatory 
bowel disease in the remission phase as much as possible. 
Dietary fatty acids are involved in several inflammatory pro-
cesses; the ω-6 family is mainly proinflammatory. Parenteral 
fatty acid supplementation modulates immunological mark-
ers considerably faster than oral intake. Thus, we evaluated 
whether parenteral infusion of lipid emulsion in which the 
ω-6 content was partially replaced by ω-9 or medium-chain 
triglycerides would decrease the damage caused by experi-
mental colitis.
Introduction
Ulcerative colitis (UC) and Crohn disease are the 2 main sub-
types of inflammatory bowel diseases (IBD). UC affects 
mainly the colon, and inflammatory changes are limited to the 
mucosa.1 The etiology of IBD is poorly understood. Defects in 
mucosal barrier function and deregulated immune recognition 
of gut microbiota in genetically susceptible individuals are 
supported by epidemiological data.2 In addition, environmen-
tal factors may also be linked to IBD.
Increased ingestion of ω-6 polyunsaturated fatty acids 
(n-6 PUFA), mainly arachidonic acid or its precursor, linoleic 
acid, has been discussed as a potential contributor for IBD. 
Elevated levels of n-6 PUFA may contribute to creating a pro-
inflammatory environment, whereas a reduction in n-6 PUFA 
intake could promote an environment less susceptible to 
inflammation.3,4
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Partial Replacement of ω-6 Fatty Acids With Medium-Chain 
Triglycerides, but Not Olive Oil, Improves Colon Cytokine 
Response and Damage in Experimental Colitis
Pedro L. Bertevello, MD, PhD1; Leticia De Nardi, MS, RD1; 
Raquel S. Torrinhas, MS, BSc1; Angela F. Logullo, MD, PhD2; 
and Dan L. Waitzberg, MD, PhD1
Abstract
Background: Soybean oil is rich in ω-6 fatty acids, which are associated with higher incidence and more severe cases of inflammatory 
bowel diseases. The authors evaluated whether partial replacement of soybean oil by medium-chain triglycerides (MCTs) or olive oil 
influenced the incidence and severity of experimental ulcerative colitis by using different parenteral lipid emulsions (LEs). Methods: 
Wistar rats (n = 40) were randomized to receive parenteral infusion of the following LE: 100% soybean oil (SO), 50% MCT mixed with 
50% soybean oil (MCT/SO), 80% olive oil mixed with 20% soybean oil (OO/SO), or saline (CC). After 72 hours of infusion, acetic 
acid experimental colitis was induced. After 24 hours, colon histology and cytokine expression were analyzed. Results: SO was not 
significantly associated with overall tissue damage. MCT/SO was not associated with necrosis (P < .005), whereas OO/SO had higher 
frequencies of ulcer and necrosis (P < .005). SO was associated with increased expression of interferon-γ (P = .005) and OO/SO with 
increased interleukin (IL)–6 and decreased tumor necrosis factor–α expression (P < .05). MCT/SO appeared to decrease IL-1 (P < .05) 
and increase IL-4 (P < .001) expression. Conclusions: Parenteral SO with high concentration of ω-6 fatty acids was not associated with 
greater tissue damage in experimental colitis. SO partial replacement with MCT/SO decreased the frequency of histological necrosis and 
favorably modulated cytokine expression in the colon; however, replacement with OO/SO had unfavorable effects. (JPEN J Parenter 
Enteral Nutr. 2012;36:442-448)
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The production of proinflammatory cytokines, such as 
tumor necrosis factor–α (TNF-α), interleukin (IL)–1, and IL-6, 
can be stimulated by the leukotriene B4, the most powerful 
metabolite of arachidonic acid.5 In both forms of IBD, 
increased levels of these proinflammatory cytokines have been 
observed.6-8 This suggests that such mediators may play a role 
in determining the severity of the disease. Moreover, the clini-
cal efficacy of therapies that target cytokines indicate that 
these mediators are deregulated and could contribute to aggra-
vation of IBD and other chronic inflammatory conditions.9 
Thus, reducing n-6 PUFA intake by introducing other fatty 
acids (FAs), primarily n-9 monounsaturated FA and medium-
chain triglycerides (MCTs), may have beneficial immunomod-
ulatory effects in UC.3
We hypothesized that decreased concentrations of n-6 
PUFA would be associated with changes in colonic cytokine 
expression and lower incidence and severity of UC. Parenteral 
FA supplementation has the advantage of rapidly modulating 
immunological markers (48–72 hours), and it avoids the diges-
tive and absorptive FA losses that usually occur with oral and 
enteral intake.10,11
We tested our hypothesis by studying the effect of commer-
cially available parenteral lipid emulsions (LEs) with different 
concentrations of n-6 PUFA on the incidence and severity of 
experimentally induced UC in rats. A soybean oil–based LE (a 
rich source of n-6 PUFA) was compared to 2 other LEs that are 
rich in either MCTs or olive oil; both of these LE contain 
approximately 50% less n-6 PUFA than soybean oil LE.
Materials and Methods
Animals
The study protocol was approved by the Research Ethical 
Committee (CAPPesq), School of Medicine, University of São 
Paulo (FMUSP), São Paulo, Brazil. Forty adult male Wistar 
rats (250–300 g) were obtained from the Vivarium Center 
(Biotério Central) of the School of Medicine, University of 
São Paulo. Prior to the experimental procedures, animals were 
adapted for 5 days at controlled room temperature (22 ± 2°C), 
under day-night light cycles, in metabolic cages, with free 
access to standard rodent chow and water. In sequence, 2 
weeks before the experimental procedures, the animals were 
treated with vermifuge praziquantel (25 mg/kg body weight) 
and ivermectin/pyrantel (2.0 µg/kg body weight), both from 
Merck Sharp & Dohme (Haar, Germany).
Parenteral Access
Animals were anesthetized with an intraperitoneal injection of 
ketamine (100 mg/kg of body weight), and parenteral access 
was achieved by jugular vein cannulation, according to a stan-
dard technique,12 followed by a connection to a swivel 
apparatus to allow the animals free mobility.13 All rats were 
then housed in metabolic cages. All intravenous treatments 
were delivered with a peristaltic pump (0.5 mL/h rate) for 72 
hours.
The animals were randomized for intravenous infusions with 1 
of 4 regimens. The control group (CC) received 0.9% saline solu-
tion; the soybean oil group (SO) received Lipovenoes 20% 
(Fresenius-Kabi, Bad Homburg, Germany), which comprised 
100% soybean oil, rich in n-6 PUFA; the medium-chain triglycer-
ides group (MCT/SO) received Lipofundin 20% (B. Braun 
Melsungen, Melsungen, Germany), a physical mixture of 50% 
MCTs and 50% soybean oil; and the olive oil group (OO/SO) 
received ClinOleic 20% (Baxter, Maurepas, France), which com-
prised 80% olive oil, rich in n-9 monounsaturated FA, and 20% 
soybean oil. The FA compositions of the different LEs are listed in 
Table 1. All LE regimens were delivered at doses of 8–9 g of fat/
kg body weight. The CC received a standard oral diet (AIN-93M), 
and the LE-treated groups received lipid-free oral diets.
Experimental Colitis
After 72 hours of intravenous infusion, experimental colitis 
was induced in all of the animals in this study by an intrarectal 
administration of 0.5 mL of 10% acetic acid solution, as 
described elsewhere.8,14 The animals were killed 24 hours after 
the colitis procedure. Before they were killed, the rats were 
weighed and anesthetized. Laparotomy was performed for 
complete colon resection and sample collection. The colon 
specimens were washed with saline solution and dissected lon-
gitudinally for macroscopic analysis. Then, specimens were 
placed in a 10% formaldehyde buffer. After dehydration and 
standard processing, the samples were paraffin-embedded in 
individual blocks for further histological, cytokine expression, 
and immunohistochemistry analyses.
Macroscopic and Histological Analyses
The specimens were evaluated macroscopically for the pres-
ence of hyperemia, scaling, mucus, ulcer, edema, ischemia, 
and tissue necrosis.
Specimens were cut into 3.0-µm sections and stained with 
hematoxylin-eosin. Sections were histologically analyzed for the 
presence of reactive lymphoid hyperplasia, extensive exulcer-
ation, extensive ulceration, inflammatory infiltrates in the submu-
cosa and muscle, and transmural necrosis. All of the evaluations 
were performed with an optical microscope equipped with 200–
400× objectives (standard objectives; Nikon, Tokyo, Japan; and 
Zeiss, Jena, Germany) by 2 independent observers who were 
blinded to the experimental groups. Measurements from 5 ran-
domized, high-power optical fields were averaged for each rat. 
Disagreements regarding observations between the 2 investiga-
tors (eg, presence vs absence of necrosis) were reviewed simul-
taneously and a consensus was reached.
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Cytokine Expression
We determined the expression of cytokines IL-1, IL-4, IL-6, 
TNF-α, and interferon (IFN)–γ with immunohistochemical 
methods that were standardized and described previously.8 
Briefly, after deparaffinization, 3.0-µm histological sections of 
the colon were incubated overnight with primary cytokine-
specific antibodies. Antibodies were diluted with phosphate-
buffered saline (PBS) 1:300 for anti-rIL-1β and 1:30 for 
anti-rIL-4, anti-rIL-6, anti-rIFN-γ, and anti-rTNF-α (all from 
R&D Systems, Minneapolis, Minnesota). All of the test reac-
tions (tissue with primary antibody) were run in parallel with 
negative controls (tissue and reaction buffer with no primary 
antibody).
Two observers, also blinded to the experimental groups, 
counted positive cells in 10 different fields (400× magnifica-
tion) with high concentrations of positively identified inflam-
matory cells (hot spots). Stromal and epithelial cells were not 
counted. A mean of the preliminary 10 results obtained by 
each observer for each rat was obtained and then a new mean 
was calculated considering each of these 2 obtained means. 
Cases with severe disagreement were reviewed simultane-
ously and a diagnostic consensus was reached.
Statistical Analysis
Normal distributions of variables were assessed with the Kol-
mogorov-Smirnov test. Data are expressed as the mean ± 
standard deviation. For macroscopic and histological 
analyses, the Monte Carlo χ2 exact test was used to assess 
differences among groups. For cytokine evaluation, com-
parisons between groups were carried out with 1-way analy-
sis of variance (ANOVA) and post hoc comparisons with 
Tukey’s test; when normality or equal variance failed, the 
Kruskal-Wallis and Dunn post hoc tests were used. Fisher’s 
exact test was performed to assess correlations between 
cytokine expression and macroscopic alterations. P values 
<.05 were considered statistically significant. Statistical 
analyses were carried out with SPSS 10.0 for Windows 
(SPSS, Inc, an IBM Company, Chicago, Illinois).
Results
Body Weight and Infusion Volume
Regardless of nutrition treatment, all of the rats lost body 
weight (8.86 ± 3.16 g on average), with no statistical 
differences among groups (P = .175). The animals in the OO/
SO group exhibited less food intake (16.2 ± 4.19 g) than ani-
mals from the other groups (P < .05). There were no statisti-
cal differences in the infused volumes of LE or saline among 
the 4 groups.
Macroscopic Alterations
Macroscopic alterations were observed in the colons of all ani-
mals subjected to colitis (Table 2). Necrosis was the only mac-
roscopic alteration observed that was statistically different 
Table 1. Main Fatty Acids Composition (Weight Percentage) of Studied Lipid Emulsions
Fatty Acids SOa MCT/SOb OO/SOc
Caproic (C6:0) — <1 —
Caprylic (C8:0) — 25.6–46.1 —
Capric (C10:0) — 19.3–34.8 —
Lauric (C12:0) — <3 —
Myristic (14:0) 0.1 — —
Palmitic (C16:0) 11.8 7.2–13.6 12.9
Stearic (C18:0) 4.0 2.8–5.0 3.5
α-Linolenic (C18:3 n-3) 6.8 3.4–6.1 2.3
Eicosapentaenoic (C20:5 n-3) — — —
Docosapentaenoic (C22:5 n-3) — — —
Docosahexaenoic (C22:6 n-3) — — 0.5
Linoleic (C18:3 n-6) 52.1 26.8–28.3 17.2
Arachidonic (C20:4 n-6) — — 0.5
Palmitoleic (C16:1 n-7) — — 0.7
Oleic (C18:1 n-9) 23.5 13.0–23.4 56.5
Dashes indicate nonsignificant quantity. MCT, medium-chain triglyceride; OO, olive oil; SO, soybean oil. Data supplied by the manufactures of the lipid 
emulsions:
aLipovenoes 20% (Fresenius-Kabi, Bad Homburg, Germany).
bLipofundin 20% (B. Braun, Melsungen, Germany).
cClinOleic 20% (Baxter, Maurepas, France).
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among groups. It occurred less frequently in the SO group than 
in the OO/SO group (P = .0235).
Histological Analysis
Higher frequencies of ulcers (P < .001) and necrosis (P = .003) 
were observed in the OO/SO group compared to the other groups. 
Necrosis was absent in the MCT/SO group. Hyperplasia, muscle, 
and submucosal inflammatory infiltrates were not significantly 
different between groups (Figure 1).
Cytokine Expression
The SO group had higher IFN-γ expression in the colon com-
pared to all other groups (P = .005). The MCT/SO group had 
significantly lower IL-1 expression (P < .05) and higher IL-4 
expression (P < .001) compared to the SO and OO/SO groups.
The OO/SO group had significantly higher IL-6 production 
(P < .05) compared to all other groups and lower TNF-α 
expression compared to the CC group (P = .042). Cytokine 
expression results are listed in Table 3.
An analysis of the correlations between cytokine expression 
and macroscopic alterations revealed that high levels of IL-6 and 
IFN-γ were positively associated with the presence of histological 
necrosis in the CC group (P = .005).
Discussion
Among the several experimental models available for UC 
research, we decided to use acetic acid–induced UC in rats to 
evaluate whether reduced infusion of potentially proinflamma-
tory n-6 PUFA would affect tissue damage and cytokine expres-
sion in the colon. After injury, cytokine expression may peak at 
different times, but based on the results of previous studies, rea-
sonable changes should be detectable after 24 hours.15,16 In a 
previous study performed by our laboratory, after 24 hours of 
acetic acid–induced colitis, we observed a significant increase in 
IL-1, IFN-γ, and IL-6 expression, as well as a significant increase 
in the frequency of colonic necrosis compared to noncolitis con-
trols.8 In addition, the increase in both IFN-γ and IL-6 was sig-
nificantly associated with the presence of histological colonic 
necrosis in the group with colitis.8
We compared commercial parenteral soybean LE with a 
high concentration of n-6 PUFA (about 50%) to 2 other LEs 
with lower concentrations of these FAs (about 20%–25%), 
both of which claim to have a neutral impact on the immune 
response. The amount of fat supplementation in the experi-
mental groups was estimated with the goal of providing 30%–
40% of nonprotein calories, similar to the percentages used in 
studies by other authors,17-20 and in accordance with the recom-
mendations of the European Society for Clinical Nutrition and 
Metabolism (ESPEN).21
We found that infusion of parenteral LE modified the inci-
dence and severity of rat colonic tissue damage and cytokine 
profile expression 24 hours after insult, apparently independent 
of reductions in n-6 PUFA concentrations. Soybean oil–based 
LE increased proinflammatory IFN-γ, but rats in this group had 
significantly less frequent macroscopic colonic necrosis when 
compared to rats infused with OO/SO LE. This finding is sup-
ported by a previous study in which mice were fed an arachi-
donic acid–enriched diet followed by induction of colitis by 
dextran sodium sulfate.22 The mice in this study had increased 
concentrations of colonic arachidonic acid, but this was not 
associated with increased colonic inflammation.22
In our experiment, 24 hours after colitis induction, cytokine 
response and histological damages were different among the 
groups infused with diluted n-6 PUFA LE. The MCT/SO infu-
sion favorably modulated colonic cytokine expression by 
reducing proinflammatory IL-1 and increasing anti-inflamma-
tory IL-4, and there was no histological presence of necrosis. 
By contrast, rats that received infusions of OO/SO, which is 
rich in n-9 monounsaturated FA (MUFA), had decreased TNF-
α levels but increased proinflammatory cytokine IL-6 levels. 
Histological analysis identified higher frequencies of ulcer and 
necrosis in the OO/SO group compared to all other rat groups.
The 3 LEs that we used in this study are not composed 
exclusively of FAs. In addition to egg phosphatides and glyc-
erol, they also contain substantial amounts of the antioxidant 
α-tocopherol, which has anti-inflammatory properties that 
could influence our findings. However, olive oil–based LE has 
a high concentration of α-tocopherol (32 mg/L from olive oil; 
data provided by the manufacturer) and did not have signifi-
cant anti-inflammatory effects. Therefore, we propose that the 
Table 2. Colon and Mucosa Macroscopic Alteration in 
Rats Observed After 24 Hours of Colitis Induction
CC SO MCT/SO OO/SO
Colon
 Hyperemia 2 5 4 3
 Edema 2 0 0 2
 Ischemia 0 2 2 3
 Necrosis 8 4 5 4
Mucosa
 Hyperemia 1 5 4 1
 Edema 0 2 1 0
 Ischemia 0 0 0 0
 Necrosis 7 2 7 8*
 Ulcer 9 6 5 6
 Scaling 0 4 3 1
 Mucus 0 0 0 0
The data are expressed in absolute numbers of positive events, mean 
value/group. Control rats (CC) received saline infusions, and test rats 
received lipid emulsion infusions that primarily contained soybean oil 
(SO), medium-chain triglycerides (MCT/SO), or olive oil (OO/SO). 
Significant changes are indicated as *P = .0235 vs SO.
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immunomodulatory properties of these LEs are associated 
with their FA composition rather than due to other ingredients. 
If this is so, then the varied effects of MCT/SO and OO/SO were 
likely a result of the type of FA used to dilute the soybean oil 
rather than due solely to the reduced amounts of infused n-6 
PUFA.
Traditionally, MCTs have been considered only as an 
energy source, but recent data indicate that MCTs may also 
have immunomodulatory effects. We and others have reported 
that MCT-containing LE can modulate leukocyte functions in 
vitro, in vivo, and ex vivo; these functions include monocyte 
recruitment stimulation,17,23-27 increased numbers of phagocy-
tosing macrophages,17 and increased respiratory burst with the 
production of reactive oxygen species by polymorphonuclear 
leukocytes.26,28-30 In addition, mice fed with MCT-enriched 
diets have lower plasma proinflammatory (TNF-α and IL-1β) 
and higher plasma anti-inflammatory (IL-10) responses to 
endotoxin compared to n-6 PUFA-, n-9 MUFA-, and n-3 PUFA-
enriched diets.31
In another study about the effects of MCT in colitis, in a 
model of spontaneous intestinal inflammation in IL-10-
deficient mice, partial replacement of dietary n-6 PUFA with 
MCT decreased the incidence of colitis.32 Parenteral infusion 
of MCT-based LE in rats with induced colitis was also associ-
ated with protection of the mucosa14 and reduced intestinal 
atrophy.33
n-9 MUFAs have been associated with neutral effects on 
immune and inflammatory functions.29,34,35 In the present 
study, we found that OO/SO LE infusion did not have a neutral 
effect and did not prevent colon damage. Instead, it increased 
the local expression of IL-6. High serum concentrations of 
inflammatory markers, such as IL-6 and C-reactive protein 
(CRP), were previously associated with anorexia.36 Thus, the 
significantly elevated levels of IL-6 that we observed in the 
 
Figure 1. Histological parameters observed after 24 hours of colitis induction. Control rats (CC) received saline infusion, and test rats 
received lipid emulsion infusion that primarily contained soybean oil (SO), medium-chain triglycerides (MCTs/SO), or olive oil (OO/
SO). The data are expressed in absolute numbers, mean value/group and SD. Significant changes are indicated as follows: 
*P < .001, OO/SO > CC, SO, and MCT/SO; #P < .005, OO/SO > CC, SO, and MCT/SO. Necrosis was absent in MCT/SO (#P < .005 
when compared to other groups).
Table 3. Cytokine Expression in Rats After 24 Hours of Colitis Induction
Groups IL-1 IL-4 IL-6 IFN-γ TNF-α
CC 9.29 ± 4.26 7.92 ± 3.90 8.71 ± 2.20 5.51 ± 2.06 16.55 ± 7.21
SO 14.14 ± 8.38 4.59 ± 0.98 7.46 ± 0.54 9.08 ± 2.99# 16.29 ± 3.07
MCT/SO 4.56 ± 3.43* 11.15 ± 3.37* 7.32 ± 2.20 4.87 ± 0.95 15.66 ± 4.71
OO/SO 15.81 ± 11.18 5.86 ± 1.98 11.15 ± 1.07# 6.19 ± 2.39 10.19 ± 4.70§
The data are expressed in number of positive cells, mean ± standard deviation. IFN-γ, interferon-γ; IL, interleukin; TNF-α, tumor necrosis factor–α. Control 
rats (CC) received saline infusions, and test rats received lipid emulsion infusions that primarily contained soybean oil (SO), medium-chain triglycerides 
(MCTs), or olive oil (OO). Significant changes are indicated as follows: *P < .05 vs SO and OO/SO; #P < .05 vs all groups; and §P < .05 vs CC.
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OO/SO group could explain, in part, why this group ingested 
less oral diet than the other groups.
In contrast to our findings, a previous study in mice with 
dextran sodium sulfate–induced colitis found that oral treat-
ment with extra-virgin olive oil led to lower levels of the 
colonic proinflammatory cytokine cyclooxygenase-2 (COX-
2), and inducible nitric oxidase synthase (iNOS) expression 
was significantly lower than in mice treated with sunflower 
oil.37 The differences between these data and ours can be 
explained by the differences in the experimental models used, 
such as the method of colitis induction and the route by which 
animals were fed.
To the best of our knowledge, this study was the first to 
evaluate the effects of olive oil–based LE infusion on colitis. 
Olive oil has been used as a placebo in studies that assessed 
other FAs in colitis treatments, mainly n-3 PUFA.1,38,39 Our 
findings suggest that olive oil should not be used as a placebo in 
inflammatory conditions because it may not be innocuous. 
Nonneutral effects of n-9 MUFA were observed by Gassull et 
al40 in humans. In their randomized, double-blind study, the 
remission rate of active Crohn disease was significantly lower 
in patients after 4 weeks of treatment with an enteral diet rich in 
n-9 MUFA (27%) compared to those treated with an enteral diet 
rich in n-6 PUFA (63%).40 However, it should be emphasized 
that human inflammatory bowel diseases are physiopathologi-
cally different from chemically induced acetic colitis, which 
precludes any generalizations to humans based on our results.
One possible mechanism that could partially explain the 
increased IL-6 production and histological necrosis observed with 
OO/SO-based LE infusion is a possible change in the composition 
of lipid rafts on the surface of leukocytes of the gut-associated 
lymphoid tissue (GALT) system and/or colonocytes. Lipid rafts 
are membrane microdomains that are responsible for modulating 
receptor-mediated signal transduction, thus influencing cell acti-
vation. Diet and plasma-derived nutrients may modulate inflam-
matory outcomes by altering lipid raft–associated cellular 
signaling. For example, ω-3 FAs have been shown to activate leu-
kocyte function by altering lipid raft composition.41 The highly 
unsaturated n-3 molecules can increase membrane fluidity and 
disrupt lipid rafts, impairing the activation of lipid raft–associated 
receptors (ie, proinflammatory receptors). The opposite may 
occur with the low-unsaturated n-9 FA,42 resulting in excessive 
activation of lipid raft–associated receptors and their pathways. 
This potential mechanism should be explored in future studies.
In summary, we observed that infusion of parenteral LE 
with different concentrations of n-6 PUFA before the induction 
of experimental colitis had very different effects on the colonic 
inflammatory response by altering cytokine expression and 
affecting the incidence and severity of colonic tissue damage. 
Our main finding was that partial replacement of soybean oil 
LE rich in n-6 PUFA with MCTs, but not with olive oil, was 
advantageous. These changes are probably due to distinct FA 
profiles, rather than solely to reduced levels of infused n-6 
PUFA.
The authors thank Fresenius-Kabi, B. Braun, and Baxter for 
kindly providing the lipid emulsions and Abbott Laboratories 
for the peristaltic pumps.
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